ATRA Stock Price Prediction 2026
Atara Biotherapeutics, Inc
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing distribution (CMF: -0.3941)
- Recent pattern: Doji - Indecision pattern
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 33.3% upside potential.
Volume Trend: Distribution
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $5.18 | -0.4% |
| 90 Days | $5.14 | -1.2% |
| 6 Months | $5.08 | -2.3% |
| 1 Year | $4.96 | -4.6% |
| 2 Years EXTENDED | $4.46 | -14.2% |
| 3 Years EXTENDED | $4.02 | -22.7% |
More ATRA Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results